Lilly confirms date and conference call for fourth-quarter 2024 financial results and 2025 financial guidance announcement

Go back to Lilly confirms date and conference call for fourth-quarter 2024 financial results and 2025 financial guidance announcement

BofA Securities Reiterates Buy Rating on Eli Lilly (LLY)

January 24, 2025 12:14 PM EST

BofA Securities analyst Tim Anderson reiterated a Buy rating and $997.00 price target on Eli Lilly (NYSE: LLY).

The analyst comments "This morning, Novo Nordisk (NOVO) shared topline data from its ph1/2a study with subQ amycretin in 125 patients with overweight or obesity a... More